Mohamad Khawandanah to Immunotherapy, Adoptive
This is a "connection" page, showing publications Mohamad Khawandanah has written about Immunotherapy, Adoptive.
Connection Strength
0.051
-
Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center. Bone Marrow Transplant. 2022 06; 57(6):1025-1027.
Score: 0.051